Financings Of The Fortnight: Is Merck Joining Other Recent Entrants Into Corporate Venture?
This article was originally published in The Pink Sheet Daily
Executive Summary
Plus news on recent financings by Acetylon, Tengion, Advanced BioHealing and SymBio Pharmaceuticals.
You may also be interested in...
Financings Of The Fortnight Spies The Debuts Of Five New Health Care Funds
Plus news on recent financings by InterMune, Orphazyme, Valeritas and Crescendo Bioscience.
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.